Announcement of the 47th ISOBM Conference

On behalf of the Board of Directors of the International Society of Oncology and Biomarkers (ISOBM), we are pleased to provide you with initial information about the Annual Conference 2025:

The focus of this Conference will be on biomarker research and its clinical application, molecular diagnostics, technological breakthroughs and artificial intelligence leading to a “New Era of Biomarkers in Oncology” and improving diagnosis, therapy monitoring and patient care through the course of cancer disease.

The Conference aims to bring together leading academic scientists, young and experienced researchers, medical clinicians and technology specialists from all fields of oncology to exchange and share their research results and experiences with emphasis on new biomarkers, technologies and applications in cancer care.

Oral and poster presentations, roundtable discussions and special topic seminars, workshops and room for interaction with colleagues and industry partners will provide new insights, constructive discussions and opportunities for networking and further collaborations.

Key Topics of the Conference

Key topics of the conference include:

  • Molecular pathology and blood-based biomarkers
  • Liquid profiling/liquid biopsy
    ctDNA, CTCs, epigenetics, fragmentomics
  • Protein-based markers, tumor markers
  • Extracellular vesicles and associated markers
  • Immune diagnostics
  • Proteomics and metabolomics
  • Technological breakthroughs
  • Evidence-based medicine (EBM)
  • Standardization and harmonization
  • Biomarkers for solid and hematological cancers
  • Early cancer detection and screening
  • Prognostic and predictive biomarkers
  • Monitoring of therapy response and toxicity
  • Targeted and immune therapies, cancer vaccines
  • Imaging technologies
  • Advanced biostatistics and algorithms
  • Artificial intelligence and machine learning
  • Clinical biomarker trials
  • Biobanking and sample collections
  • Personalized medicine

You will find more information on this page soon.

Conference Location

The Conference will take place in the lovely “Blue Land” of Murnau (www.dasblaueland.de/en/) in the “greater Munich area” in Southern Bavaria that has inspired and stimulated numerous expressionistic artists and painters of the early 20th century around the “Blue Rider” (Blaue Reiter) group led by Wassily Kandinsky, Gabriele Münter and Franz Mark who lived and worked here.



"We are looking forward to a really inspiring conference and many active participants starting together with us into a “New Era of Biomarkers in Oncology”."

Prof. Stefan Holdenrieder

Conference President


ISOBM 2025 - Information on Sponsorship

The symposium is supported by industry.

If you are interested in supporting the conference as a sponsor, please contact us at

isobm[at]trillium[dot]de


Organizer

International Society of Oncology and Biomarkers (ISOBM)

14 City Quay
DDI 3JA Dundee
UK

represented by its President
Prof. Dr. Stefan Holdenrieder

Conference Agency

Trillium GmbH Medizinischer Fachverlag

Jesenwanger Str. 42 b
82284 Grafrath
Germany